2024-11-27 - Analysis Report
## Merck & Co Inc (MRK) Stock Analysis Report

**1. Performance Comparison and Divergence:**

Merck & Co Inc (MRK), a leading pharmaceutical company, has shown a cumulative return of 71.51% over the period analyzed, compared to the S&P 500 (VOO) return of 128.31%. This represents a lag of -56.8%. The relative divergence of -9.6% indicates that MRK's performance is in the lower decile relative to its historical performance against the S&P 500.  The provided data suggests MRK underperformed the S&P 500 significantly.

**Alpha and Beta Analysis:**

The provided alpha and beta analysis reveals fluctuating performance relative to the market.  While alpha is generally positive, indicating some outperformance, it's not consistently high.  Beta values mostly hover around 1, suggesting the stock's volatility is similar to the overall market, with some periods exhibiting higher market sensitivity.  The market capitalization has shown consistent growth over the analysed period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 2.7% | 15.6% | -8.8% | 1.6 | 135.8 |
| 2016-2018  | 16.9% | 15.6% | 7.1% | 1.5 | 184.4 |
| 2017-2019  | 18.2% | 15.6% | 3.3% | 1.4 | 219.5 |
| 2018-2020  | 16.7% | 25.8% | 2.9% | 1.0 | 197.4 |
| 2019-2021  | 5.3% | 25.8% | -20.7% | 1.1 | 193.9 |
| 2020-2022  | 11.7% | 25.8% | 4.4% | 1.0 | 280.7 |
| 2021-2023  | 15.8% | 19.5% | 5.3% | 1.2 | 275.8 |
| 2022-2024  | 12.5% | 25.6% | 3.2% | 1.1 | 250.9 |


**2. Recent Price Movement:**

* **Closing Price:** $101.16 (Last Market: $101.29)
* **5-day Moving Average:** $98.84
* **20-day Moving Average:** $100.22
* **60-day Moving Average:** $108.24

The stock price is currently below its 20 and 60-day moving averages, suggesting a short-term downtrend.


**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 48.47 – This indicates the stock is nearing neutral territory, neither overbought nor oversold.
* **PPO (Percentage Price Oscillator):** 0.47 – A positive value suggests upward momentum, but it's relatively low, indicating weak momentum.
* **Relative Divergence (20-day):** -9.7% –  This shows a recent short-term downward trend.  The slight difference between the last market price and closing price is not significant enough to suggest a rapid price swing.

The expected return of 0.0% indicates that based on the current analysis, there is no significant expected return above the benchmark S&P 500 index over a long-term horizon (2 years or more).

**4. Recent Financial Performance:**

The provided earnings data shows some volatility in EPS and revenue.  While revenue remains relatively stable, EPS fluctuates. Note there is a duplicate entry for 2024-11-06.  Further analysis is needed to compare these results to analyst expectations and to determine whether these results are a cause for concern.

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2024-11-06 | 1.25 | $16.66 B       |
| 2024-08-05 | 2.15 | $16.11 B       |
| 2024-05-03 | 1.88 | $15.78 B       |
| 2023-11-03 | 1.87 | $15.96 B       |
| 2024-11-06 | 1.87 | $15.96 B       |


**5.  (Added based on data provided) Revenue and Profitability & Capital and Profitability:**

**Revenue and Profitability:**  Profit margins are consistently high (73-77%), indicating strong profitability. Revenue is relatively stable, showing some fluctuation quarter-to-quarter.

| Quarter    | Revenue    | Profit Margin |
|------------|------------|----------------|
| 2024-09-30 | $16.66B    | 75.51%         |
| 2024-06-30 | $16.11B    | 76.76%         |
| 2024-03-31 | $15.78B    | 77.56%         |
| 2023-12-31 | $14.63B    | 73.26%         |
| 2023-09-30 | $15.96B    | 73.29%         |


**Capital and Profitability:** ROE shows significant variability, indicating fluctuating profitability and effectiveness in using equity.  A negative ROE in 2023-12-31 is a concern.

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2024-09-30 | $44.50B    | 7.09%   |
| 2024-06-30 | $43.58B    | 12.52%  |
| 2024-03-31 | $40.36B    | 11.80%  |
| 2023-12-31 | $37.58B    | -3.26%  |
| 2023-09-30 | $41.25B    | 11.50%  |



**6. News and Recent Issues:**

*(This section requires access to real-time news sources such as Shacknews, FINBOLD, etc., to provide current information on earnings announcements, analyst opinions, and recent market outlook for MRK.  Please provide relevant news articles for a comprehensive analysis.)*  This section would include a summary of recent news affecting MRK's stock price, including earnings reports and any analyst upgrades or downgrades.

**7. Overall Analysis:**

MRK's performance has lagged the S&P 500 over the analyzed period. While the company shows strong profit margins and generally positive alpha, recent EPS volatility and a negative ROE in Q4 2023 raise concerns.  Technical indicators suggest a neutral to slightly bearish sentiment.  A more in-depth analysis including the missing news data and a comparison to analyst expectations is crucial for a complete evaluation. The long-term outlook, given the current data, is not significantly positive in relation to the S&P 500.

**8. Disclaimer:** This analysis is based on the limited data provided and should not be considered financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results.  Conduct thorough research and consult with a financial advisor before making any investment decisions.
